Example: Heart Attack

Search clinical trials for: Aluminum chloride

Total 29 results

NCT03433859

Recruiting

Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)

Conditions: Hyperhidrosis; Residual Limbs
NCT03416348

Recruiting

Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2

Conditions: Hyperhidrosis
NCT02028208

Completed

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

Conditions: Contact Dermatitis
NCT00509886

Completed

Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating

Conditions: Hyperhidrosis; Excess Sweating
NCT03236012

Recruiting

Hyperhidrosis in Patients With Amputations-Botox

Conditions: Hyperhidrosis
NCT04465539

Recruiting

The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning

Conditions: Potential Therapeutic Role
NCT04742738

Recruiting

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

Conditions: COVID-19 (Healthy Volunteers)
NCT03382418

Completed

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

Conditions: HIV Infections
NCT04582344

Recruiting

Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)

Conditions: COVID-19
NCT00347555

Completed

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly

Conditions: Plasmodium Falciparum Malaria
NCT04527575

Active, not recruiting

Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19

Conditions: Covid19
NCT01026246

Completed

EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Conditions: Plasmodium Falciparum Malaria
NCT04780035

Active, not recruiting

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

Conditions: COVID-19
NCT01717950

Completed

Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults

Conditions: Hookworm Infection; Hookworm Disease
NCT04032093

Active, not recruiting

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Conditions: Respiratory Tract Infection
NCT02661490

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

Conditions: Norovirus
NCT04563533

Recruiting

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Conditions: Acute Gastroenteritis
NCT01459393

Completed

Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment

Conditions: Actinic Keratosis
NCT01977196

Completed

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

Conditions: Healthy
NCT04651790

Recruiting

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults

Conditions: Covid19; Vaccines
NCT02472548

Completed

A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine

Conditions: Respiratory Syncytial Virus
NCT04071158

Completed

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Conditions: Respiratory Tract Infection
NCT04658667

Not yet recruiting

HIV Vaccine in HIV-uninfected Adults

Conditions: HIV
NCT04314895

Recruiting

Trial of NanoPac Intratumoral Injection in Lung Cancer

Conditions: Lung Cancer, Nonsmall Cell; Lung Cancer; Lung Cancer, Small Cell; Neoplasm of Lung
NCT04722003

Not yet recruiting

Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

Conditions: Gonorrhoea